Skip to main content
Skip Navigation

Impact of a Statewide Livestock Antibiotic Use Policy on Resistance in Human Urine Isolates: A Synthetic Control Analysis

February 01, 2023
Environmental Health Perspectives

Joan A. Casey, 
Sara Y. Tartof, 
Meghan F. Davis, 
Keeve E. Nachman, 
Lance Price, 
Cindy Liu, 
Kalvin Yu, 
Vikas Gupta, 
Gabriel K. Innes, 
Hung Fu Tseng, 
Vivian Do, 
Alice R. Pressman,

Abstract

Background
On 1 January 2018, California implemented Senate Bill 27 (SB27), banning, for the first time in the United States, routine preventive use of antibiotics in food-animal production and any antibiotic use without a veterinarian's prescription. OBJECTIVES: Our objective was to assess whether SB27 was associated with decreased antimicrobial resistance among isolated from human urine.

Methods
We used U.S. nationwide monthly state-level data from BD Insights Research Database (Becton, Dickinson, and Co.) spanning 1 January 2013 to 30 June 2021 on antibiotic-resistance patterns of 30-d nonduplicate isolated from urine. Tested antibiotic classes included aminoglycosides, extended-spectrum cephalosporins (ESC), fluoroquinolones, and tetracyclines. Counts of tested and not-susceptible (resistant and intermediate, hereafter resistant) urine isolates were available by sex, age group (, year), month, and state. We applied a synthetic control approach to estimate the causal effect of SB27 on resistance patterns. Our approach created a synthetic California based on a composite of other states without the policy change and contrasted its counterfactual postpolicy trends with the observed postpolicy trends in California.

Finding
We included urine isolates, 90% among women, across 33 states. From 2013 to 2017, the median (interquartile range) resistance percentages in California were 11.9% (7.4, 17.6), 13.8% (5.8, 20.0), 24.6% (9.6, 36.4), 7.9% (2.1, 13.1), for aminoglycosides, ESC, fluoroquinolones, and tetracyclines, respectively. SB27 was associated with a 7.1% reduction in ESC resistance (-value for joint null: ), but no change in resistance to aminoglycosides, fluoroquinolones, or tetracyclines.

Discussion
Further research is needed to determine the role of SB27 in the observed reduction in ESC resistance in human populations, particularly as additional states implement similar legislation. https://doi.org/10.1289/EHP11221.